AC Immune amends Lilly collaboration for tau drug development
Go back to AC Immune amends Lilly collaboration for tau drug development| (NASDAQ: ACIU) | Delayed: 2.76 +0.07 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.69 | 52 Week High | $19.97 | |||
| Open | $2.70 | 52 Week Low | $10.36 | |||
| Day High | $2.78 | P/E | N/A | |||
| Day Low | $2.68 | EPS | $0.00 | |||
| Volume | 105,365 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1115.70 -7.3 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1123.00 | 52 Week High | $88.16 | |||
| Open | $1129.41 | 52 Week Low | $67.88 | |||
| Day High | $1131.44 | P/E | 258.26 | |||
| Day Low | $1113.29 | EPS | $4.32 | |||
| Volume | 1,837,997 | |||||

